Tumor-marker monitoring is potentially a powerful tool to accomplish these goals. For follicular cell-derived thyroid carcinoma (excluding anaplastic cancer), which accounts for approximately 97% ...

Early recurrence of thyroid cancer may be detectable using a blood test to detect a protein called ‘Thyroglobin”(Tg) according to a study Early recurrence of thyroid cancer may be detectable ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

Additionally, blood tests that measure thyroid hormone levels and tumor markers may be performed to monitor for disease progression. Treatment options for metastatic thyroid cancer after ...

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis, risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in epithelial ...

Thyroid cancer recurrence risk was not elevated among patients with high-normal vs low-normal exposure to TSH following thyroidectomy.

Head and neck, surgical, radiation, and medical oncologists in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center specialize in the diagnosis and treatment of thyroid cancer ...

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term.

The absolute risk for thyroid cancer is low among patients receiving GLP-1 RA therapy, but risk is elevated in the first year of treatment.

Thyroid cancer patients require close monitoring even after treatment, as recurrence is possible. Follow-up care usually includes regular physical exams, blood tests for thyroglobulin (a marker ...

In summary, Tg is a well-established thyroid cancer tumor marker. Its limitations center on TgAb interferences, which affect a significant subset of patients and on the fact that it is thyroid ...